Overall survival with darolutamide vs placebo in combination with androgen-deprivation therapy and docetaxel by stratification factors in the phase 3 ARASENS trial

Bertrand Tombal, Maha Hussain, Fred Saad, Karim Fizazi, Cora Sternberg, E David Crawford, Evgeny Kopyltsov, Arash Rezazadeh Kalebasty, Boris Alekseev, Álvaro Montesa-Pino, Dingwei Ye, Francis Parnis, Cruz Felipe Melo, Teuvo Tammela, Hiroyoshi Suzuki, Heikki Joensuu, Silke Thiele, Rui Li, Iris Kuss, Matthew R. Smith

    Research output: Other conference contributionAbstractScientific

    Original languageEnglish
    Publication statusPublished - 4 Jul 2022
    Publication typeNot Eligible
    EventEAU22 - Amsterdam, Netherlands
    Duration: 1 Jul 20224 Jul 2022
    https://eaucongress.uroweb.org/scientific-programme/

    Conference

    ConferenceEAU22
    Country/TerritoryNetherlands
    CityAmsterdam
    Period1/07/224/07/22
    Internet address

    Cite this